首页> 外国专利> New peptide inhibitors of human topoisomerase with high activity and specificity, for treating, for example, cancer and viral infections

New peptide inhibitors of human topoisomerase with high activity and specificity, for treating, for example, cancer and viral infections

机译:具有高活性和特异性的新型人类拓扑异构酶肽抑制剂,用于治疗例如癌症和病毒感染

摘要

Peptides (I) that inhibit human topoisomerase II alpha and their protected derivatives are new. Peptides of formula (I) and their protected derivatives are new Thr-X1-Leu-Asp-Ile-X2-X3-Asp-Leu-X4-Glu-X5-Arg-Leu-Lys-Tyr-Tyr-X6-X7-A rg-Lys-Glu-Phe-Leu-X8-X9-X10-Leu-Gly (I) X1 = Gln or Glu; X2 and X5 = Leu or Lys; X3 = Arg or Lys; X4 = Phe or Tyr; X6 = Gly or Glu; X7 and X8 = Leu or Glu; X9 = Gln or Lys; X10 = Met or norleucine An Independent claim is also included for a composition containing (I) as the active ingredient.
机译:抑制人拓扑异构酶IIα及其保护衍生物的肽(I)是新的。式(I)的肽及其保护的衍生物是新的Thr-X1-Leu-Asp-Ile-X2-X3-Asp-Leu-X4-Glu-X5-Arg-Leu-Lys-Tyr-Tyr-X6-X7- Rg-Lys-Glu-Phe-Leu-X8-X9-X10-Leu-Gly(I)X1 = Gln或Glu; X2和X5 = Leu或Lys; X3 =精氨酸或赖氨酸; X4 = Phe或Tyr; X6 =甘氨酸或谷氨酸; X7和X8 = Leu或Glu; X9 = Gln或Lys; X 10 = Met或正亮氨酸也包含包含(I)作为有效成分的组合物的独立权利要求。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号